| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/09/1998 | WO1998014177A1 Methods and compositions employing red yeast fermentation products |
| 04/09/1998 | WO1998014176A1 Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix |
| 04/09/1998 | WO1998014175A1 Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof |
| 04/09/1998 | WO1998014174A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 04/09/1998 | WO1998014173A1 Edible, low calorie compostions of a carrier and an active ingredient and methods for preparation thereof |
| 04/09/1998 | WO1998014172A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 04/09/1998 | WO1998014171A1 Method for producing liposomes with increased percent of compound encapsulated |
| 04/09/1998 | WO1998014170A1 Idiotypic vaccine in lipid based carrier for b cell disorders |
| 04/09/1998 | WO1998014169A1 Methods and compounds for treatment of abnormal uterine bleeding |
| 04/09/1998 | WO1998014168A2 Dosage form providing a sustained and ascending drug release |
| 04/09/1998 | WO1998002145A3 β-LACTAM GRANULES FREE OF ORGANIC SOLVENTS |
| 04/09/1998 | DE19740733A1 Powder composition containing absorbent resin and peptide |
| 04/09/1998 | DE19641437A1 1,3-Bis-(N-lactamyl)propane und deren pharmazeutische und kosmetische Verwendung 1,3-bis (N-lactamyl) propane and its pharmaceutical and cosmetic use |
| 04/09/1998 | DE19640062A1 Orale Zubereitung, enthaltend in einer in wässrigem Medium quellbaren Matrix wenigstens einen pharmazeutischen Wirkstoff The oral composition containing a swellable in aqueous medium matrix least one active pharmaceutical ingredient |
| 04/09/1998 | DE19639342A1 Kaugummi, enthaltend ein Süßungsmittel Chewing gum containing a sweetener |
| 04/09/1998 | DE19637936A1 Pharmaceutical composition for mucosal application |
| 04/09/1998 | CA2555678A1 Hydrophilic microparticles and methods to prepare same |
| 04/09/1998 | CA2515884A1 Dosage form and method for administering drug |
| 04/09/1998 | CA2267675A1 Method for treating allergic lung disease |
| 04/09/1998 | CA2267370A1 Liquid alendronate formulations |
| 04/09/1998 | CA2267340A1 Methods and compositions employing red yeast fermentation products |
| 04/09/1998 | CA2267305A1 Topical products as prophylactic or curative agents for bacterial skin infections |
| 04/09/1998 | CA2267248A1 Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| 04/09/1998 | CA2264524A1 Patch |
| 04/09/1998 | CA2217134A1 Sustained release formulation |
| 04/08/1998 | EP0834314A1 Granules containing pranlukast, process for producing the granules, and method of lowering cohesiveness of pranlukast |
| 04/08/1998 | EP0834312A1 Topical medicament containing diclofenac |
| 04/08/1998 | EP0834309A2 Use of a liposome solution for enhancing the activity and/or reducing the toxicity of drugs |
| 04/08/1998 | EP0834308A1 Ophthalmic formulation for treating myopia comprising dopamine agonist and cyclodextrin |
| 04/08/1998 | EP0834306A2 Water in oil cosmetic emulsion with high electrolyte content |
| 04/08/1998 | EP0833935A1 Cell line producing analgesic compounds for treating pain |
| 04/08/1998 | EP0833671A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 04/08/1998 | EP0833667A1 Stabilization of polynucleotide complexes |
| 04/08/1998 | EP0833662A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 04/08/1998 | EP0833655A1 Pharmaceutical preparation with cyclosporin a |
| 04/08/1998 | EP0833642A1 Compressed dry-granulation desogestrel tablets |
| 04/08/1998 | EP0833640A1 Pharmaceutical composition containing lamotrigine |
| 04/08/1998 | EP0833621A1 Soft gelatin capsules containing particulate material |
| 04/08/1998 | EP0833620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 04/08/1998 | EP0833619A1 Controlled release of drugs delivered by sublingual or buccal administration |
| 04/08/1998 | EP0833618A1 Solid pharmaceutical form for oral use |
| 04/08/1998 | EP0833617A1 A method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method |
| 04/08/1998 | EP0833616A1 Process for the continuous agglomeration of granules |
| 04/08/1998 | EP0833615A1 Nutritional and/or dietary composition and method of using the same |
| 04/08/1998 | EP0833614A1 System and method for producing drug-loaded microparticles |
| 04/08/1998 | EP0833613A1 Delivery vehicles comprising stable lipid/nucleic acid complexes |
| 04/08/1998 | EP0833612A1 New pharmaceutical composition with anaesthetic effect |
| 04/08/1998 | EP0833611A1 A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 04/08/1998 | EP0833610A1 Novel laxative compositions and method for making same |
| 04/08/1998 | EP0833609A1 Compositions and methods for stabilizing polymers |
| 04/08/1998 | EP0833608A2 Reverse fluorocarbon emulsion compositions for drug delivery |
| 04/08/1998 | EP0833607A1 Tar-containing composition and pharmaceutical and cosmetic preparation containing the same |
| 04/08/1998 | EP0833606A1 Stable hydroalcoholic compositions |
| 04/08/1998 | EP0833605A1 Stable hydroalcoholic compositions |
| 04/08/1998 | EP0833573A1 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals |
| 04/08/1998 | EP0773866B1 Method or producing coated tablets |
| 04/08/1998 | EP0548344B1 Collagen composites for controlled drug release |
| 04/08/1998 | EP0544874B1 Method for preparing submicron particles in the presence of lipid vesicles, and corresponding compositions |
| 04/08/1998 | CN1178471A Treatment of diabetic neuropathy |
| 04/08/1998 | CN1178467A Polyphenol fractions of tea, the use thereof and formulations containing same |
| 04/08/1998 | CN1178461A Pharmaceutical compositions comprising monoamine oxidase B inhibitors |
| 04/08/1998 | CN1178460A Use of compositions comprising stabilized biologically effective compounds |
| 04/08/1998 | CN1178459A Method and kit for preventing erectile dysfunction |
| 04/08/1998 | CN1178458A Improvements in or relating to organic compositions |
| 04/08/1998 | CN1178121A Injection for AIDs and preparation thereof |
| 04/08/1998 | CN1178118A External use disinfectant anagesic and production thereof |
| 04/08/1998 | CN1178106A Cyclosphorin-containing soft capsule preparation |
| 04/08/1998 | CN1037934C Pharmaceutical soft capsules containing lysne elonixiwate |
| 04/08/1998 | CN1037933C Preparation of coated solid medicament form having releasability in large intestine |
| 04/08/1998 | CN1037932C Preparation of oral presentation forms for acid-unstable active compounds |
| 04/08/1998 | CN1037931C Plaster without lead and its preparation |
| 04/07/1998 | US5736581 Polyglycerol polyricinoleates |
| 04/07/1998 | US5736580 Composition, device, and method for electrotransport agent delivery |
| 04/07/1998 | US5736577 Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
| 04/07/1998 | US5736553 Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine |
| 04/07/1998 | US5736542 Pharmaceutical compositions containing a staurosporine |
| 04/07/1998 | US5736533 Inhibiting colonization of streptococcus pneumoniae, hemophilus influenza or parainfluenza, burkholderia (pseudomonas) cepacia by administering binding inhibiting oligosaccharide |
| 04/07/1998 | US5736506 Mixture with polysaccharide |
| 04/07/1998 | US5736395 Transforming cells in mammal by contacting with complexes comprising an expression cassette and a nitrogen-containing amphiphile |
| 04/07/1998 | US5736392 Composition for transfecting eukaryotic cell comprising peptide-nucleic acid complex and cationic lipid capable of aggregating complex |
| 04/07/1998 | US5736380 From pimelobacter; for foods, cosmetics |
| 04/07/1998 | US5736371 Biodegradable particulate vector for transporting molecules having biological activity |
| 04/07/1998 | US5736368 Self assembled defective non-self propagating lentiviral particles |
| 04/07/1998 | US5736161 Pharmaceutical preparation for improving the bioavailability of drugs which are difficult to absorb and a procedure for obtaining it |
| 04/07/1998 | US5736159 Controlled release formulation for water insoluble drugs in which a passageway is formed in situ |
| 04/07/1998 | US5736157 Parenterally administering a therapeutically effective amount of a lipid acceptor |
| 04/07/1998 | US5736156 Anticarcinogenic agent having lactone ring protected from hydrolysis by association with surfactant or lipid; drug delivery, water solubility, nontoxic |
| 04/07/1998 | US5736155 Encapsulation of antineoplastic agents in liposomes |
| 04/07/1998 | US5736154 Multilayered, intra-lesional, interferon delivery which doesn't pass into blood stream; for treatuble carcinomas |
| 04/07/1998 | US5736153 Plaster with a supply of a medically active substance |
| 04/07/1998 | US5736152 Mixture of biodegradable, non-polymeric, water insoluble material and a biocompatible solvent that solubilizes the non-polymeric material |
| 04/07/1998 | US5736151 Antibiotic oil suspensions |
| 04/07/1998 | US5736141 Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant |
| 04/07/1998 | US5736124 Aerosol formulations containing P134a and particulate medicament |
| 04/07/1998 | US5736121 Administering stabilized aqueous suspension of gaseous precursor to patient, allowing phase transition form liquid to gas, scanning |
| 04/07/1998 | US5735934 Method for delivering a gas-supersaturated fluid to a gas-depleted site and use thereof |
| 04/07/1998 | US5735105 Encapsulation apparatus and process |
| 04/07/1998 | CA2217409A1 Pharmaceutical preparations for intranasal administration |
| 04/07/1998 | CA2216006A1 W/o emulsion with high electrolyte content and its use in dermo-cosmetics, in particular for treating irritation and/or sensitive skin |
| 04/07/1998 | CA2116785C Sustained release organic nitrite therapy |